Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)

Alex Levy,Wojciech Jurczak,Caroline Dartigeas,Marta Coscia,Peter S. Ganly,Ghassan Al-Jazayrly,Chunxiao Wang,Katherine Bao,Ching Ching Leow,Safi Shahda,Pier Luigi Zinzani

Clinical Lymphoma Myeloma and Leukemia（2022）

Cited 0|Views9
No score
Abstract
Trial in Progress.
More
Translated text
Key words
CLL,pirtobrutinib,BTKi,chronic lymphocytic leukemia,clinical trial,Trial-in-Progress
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined